Turtle Cameron
Director · Officer · SYRE, DMRA, ORKA
As of 2026-09-16, Turtle Cameron has 38 Form 4 transactions on record across 3 companies — 36 in the trailing 12 months.
Everything this person has disclosed to the SEC on Form 4 — across every company they file for — reconstructed from the public record. A filing history, not a tip sheet.
Reconstructed holdings
Reconstructed from this person's own Form 4 filings — the total each filing reported owning afterward, priced at the close on the as-of date shown. A filed position can lag the real one.
Direct and indirect holdings (e.g. through a trust or fund) are tagged separately, as filed.
Trades by company
Filing ledger
| Date | Company | Action | Shares @ price | Value | Ownership Δ | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-01 | SYRE | Sale | 8,400 @ $87.15 | $732K | −1.5% of holding | 556,640 | Form 4 |
| 2026-09-01 | SYRE | Sale | 3,700 @ $88.06 | $326K | −0.7% of holding | 552,940 | Form 4 |
| 2026-09-01 | SYRE | Sale | 2,500 @ $86.36 | $216K | −0.4% of holding | 565,040 | Form 4 |
| 2026-09-01 | SYRE | Sale | 400 @ $89.07 | $36K | −0.1% of holding | 552,540 | Form 4 |
| 2026-08-03 | SYRE | Sale | 7,157 @ $95.10 | $681K | −1.2% of holding | 574,583 | Form 4 |
| 2026-08-03 | SYRE | Sale | 5,635 @ $95.93 | $541K | −1.0% of holding | 568,948 | Form 4 |
| 2026-08-03 | SYRE | Sale | 1,392 @ $96.82 | $135K | −0.2% of holding | 567,556 | Form 4 |
| 2026-08-03 | SYRE | Sale | 800 @ $93.97 | $75K | −0.1% of holding | 581,740 | Form 4 |
| 2026-08-03 | SYRE | Sale | 16 @ $97.46 | $2K | −0.0% of holding | 567,540 | Form 4 |
| 2026-07-01 | SYRE | Sale | 10,176 @ $87.44 | $890K | −1.7% of holding | 587,364 | Form 4 |
| 2026-07-01 | SYRE | Sale | 4,234 @ $88.12 | $373K | −0.7% of holding | 583,130 | Form 4 |
| 2026-07-01 | SYRE | Sale | 590 @ $88.91 | $52K | −0.1% of holding | 582,540 | Form 4 |
| 2026-06-01 | SYRE | Sale | 8,149 @ $70.50 | $575K | −1.3% of holding | 600,834 | Form 4 |
| 2026-06-01 | SYRE | Sale | 3,557 @ $69.40 | $247K | −0.6% of holding | 608,983 | Form 4 |
| 2026-06-01 | SYRE | Sale | 3,294 @ $71.38 | $235K | −0.5% of holding | 597,540 | Form 4 |
| 2026-05-01 | SYRE | Sale | 5,300 @ $69.54 | $369K | −0.8% of holding | 622,240 | Form 4 |
| 2026-05-01 | SYRE | Sale | 3,600 @ $70.77 | $255K | −0.6% of holding | 618,640 | Form 4 |
| 2026-05-01 | SYRE | Sale | 3,100 @ $73.14 | $227K | −0.5% of holding | 614,540 | Form 4 |
| 2026-05-01 | SYRE | Sale | 1,700 @ $74.23 | $126K | −0.3% of holding | 612,840 | Form 4 |
| 2026-05-01 | SYRE | Sale | 1,000 @ $71.76 | $72K | −0.2% of holding | 617,640 | Form 4 |
| 2026-05-01 | SYRE | Sale | 300 @ $74.96 | $22K | −0.0% of holding | 612,540 | Form 4 |
| 2026-04-01 | SYRE | Sale | 12,344 @ $49.20 | $607K | −1.9% of holding | 630,196 | Form 4 |
| 2026-04-01 | SYRE | Sale | 2,656 @ $49.92 | $133K | −0.4% of holding | 627,540 | Form 4 |
| 2026-03-02 | SYRE | Sale | 9,100 @ $42.49 | $387K | −1.4% of holding | 642,540 | Form 4 |
| 2026-03-02 | SYRE | Sale | 5,900 @ $41.73 | $246K | −0.9% of holding | 651,640 | Form 4 |
| 2026-02-02 | SYRE | Sale | 14,043 @ $32.87 | $462K | −2.1% of holding | 657,540 | Form 4 |
| 2026-02-02 | SYRE | Sale | 957 @ $31.82 | $30K | −0.1% of holding | 671,583 | Form 4 |
| 2026-01-02 | SYRE | Sale | 12,709 @ $30.47 | $387K | −1.9% of holding | 674,198 | Form 4 |
| 2026-01-02 | SYRE | Sale | 2,191 @ $31.79 | $70K | −0.3% of holding | 672,007 | Form 4 |
| 2026-01-02 | SYRE | Sale | 100 @ $32.39 | $3K | −0.0% of holding | 671,907 | Form 4 |
| 2025-12-01 | SYRE | Sale | 10,995 @ $28.73 | $316K | −1.6% of holding | 690,912 | Form 4 |
| 2025-12-01 | SYRE | Sale | 4,005 @ $29.83 | $119K | −0.6% of holding | 686,907 | Form 4 |
| 2025-11-03 | SYRE | Sale | 28,155 @ $23.13 | $651K | −3.8% of holding | 718,752 | Form 4 |
| 2025-11-03 | SYRE | Sale | 16,845 @ $23.66 | $399K | −2.3% of holding | 701,907 | Form 4 |
4 award / exercise / gift records — not counted as purchases
Source: SEC Form 4 filings. Each row links to its original filing.
Research tool, not investment advice — historical frequencies, not recommendations. A product of Marovel Technologies LLC. Full terms.